Healthtech Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests
NewsDealsSocialBlogsVideosPodcasts
Nitra Raises $50M Series B to Expand AI-Driven Healthcare Back-Office Platform
Series BHealthTechHealthcare

Nitra Raises $50M Series B to Expand AI-Driven Healthcare Back-Office Platform

•March 10, 2026
•Mar 10, 2026
1

Participants

Nitra

Nitra

company

Why It Matters

By automating the most labor‑intensive administrative tasks, Nitra could slash operating costs for clinics and free physicians to focus on care, reshaping a $1 trillion U.S. healthcare spend. The sizable funding and rapid adoption signal a potential decacorn that may set new standards for AI‑driven practice management.

Key Takeaways

  • •Nitra raised $50M Series B, total $205M funding.
  • •Platform processes over $1B annually, $33M ARR.
  • •AI-driven credit card integrates back‑office functions for clinics.
  • •Over 700 clinics onboarded; aims $4B processing by year‑end.
  • •Board adds Dr. Richard Park, boosting healthcare credibility.

Pulse Analysis

Nitra’s latest funding round underscores a broader shift toward AI‑powered infrastructure in the U.S. healthcare system. While electronic health records have dominated attention for years, the back‑office—billing, procurement, and compliance—remains fragmented and costly. Nitra’s approach of embedding a credit card that automatically captures expense data, then routing it through AI agents for reconciliation and claim filing, tackles this inefficiency at scale. By converting routine transactions into data streams, the platform creates a real‑time financial operating system for clinics, a capability that traditional practice‑management software has struggled to deliver.

The timing of Nitra’s growth aligns with two market forces: supply‑chain volatility and increasing physician comfort with automation. Tariff‑induced price spikes on gloves, syringes and other consumables have forced practices to seek granular cost controls, while AI tools for clinical documentation have normalized delegating decision‑making to algorithms. Nitra leverages both trends, offering a unified marketplace—Nitra Rx and Nitra Mart—where doctors can purchase supplies directly, while AI agents handle the administrative heavy lifting. This land‑and‑expand model not only accelerates adoption but also builds a data moat, making the platform more valuable as more clinics join.

Strategically, the addition of Dr. Richard Park to the board provides deep industry credibility and opens doors to physician‑entrepreneur networks, a critical channel for scaling in a relationship‑driven market. With $205 million raised and a projected $4 billion in processing volume by year‑end, Nitra is positioned to become a decacorn and potentially redefine practice economics. If the company achieves its billion‑dollar revenue target, it could pressure legacy vendors to innovate or consolidate, accelerating the overall digital transformation of healthcare administration.

Deal Summary

Nitra, an AI-native operating platform for medical practices, announced a $50 million Series B funding round on Tuesday, bringing its total capital raised to $205 million. The round will support scaling its platform, which now processes over $1 billion in annualized volume and serves more than 700 clinics. The funding was disclosed in a Fortune article on March 10, 2026.

1

Comments

Want to join the conversation?

Loading comments...